Cat.#: ASSD-148
Description | Sulforhodamine 101, a red fluorescent dye, is used to label astrocytes and oligodendrocytes both in vitro and in vivo and is frequently used in neurophysiological experiments. Water-soluble and non-fixable. The dye is commonly used for in vivo brain imaging and allows in vivo imaging of oligodendrocytes. It may be applied topically to the exposed cortex or administered via injection. |
Size | 50 mg, 100 mg |
Applications | For used to identify astrocytes, and to counterstain astrocytes and has been extensively used with calcium-sensitive dyes to distinguish calcium signals derived from neurons and astrocytes. |
Chemical Name | 9-(2,4-Disulfophenyl)-2,3,6,7,12,13,16,17-octahydro-1H,5H,11H,15H-xantheno[2,3,4-ij:5,6,7-ij]diquinolizin-18-ium inner salt |
Molecule Weight | 606.71 |
Molecular formula | C31H30N2O7S2 |
CAS Number | 60311-02-6 |
PubChem identifier | 122180 |
MDL Number | MFCD00012407 |
Purity | >98% |
Solubility | Soluble in water (50 mM), and in DMSO (50 mM) |
Excitation | ~541 nm |
Emission | 606 nm |
Storage | Store at 4° C |
Shipping | Shipped at 4°C |
Important | Care should be taken when using the dye as it cannot be assumed that all Sulforhodamine 101 labeled cells are astrocytes. If possible, please carry out additional measures to confirm the specificity of Sulforhodamine 101 staining in their experiments. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg | inquiry |
ASSD-184 | BTA-1 (AC184) | 10 mg | inquiry |
ASSD-155 | Bromophenol blue (AC155) | 5g | inquiry |
ASSD-220 | Nitrofluorescein, Isomer 2 (AC220) | 1 g | inquiry |
ASSD-178 | 5-(Iodoacetamido)fluorescein (AC178) | 25 mg, 100 mg, 250 mg | inquiry |
ASSD-103 | DAPI Staining Solution (1mg/mL) (AC103) | 1 mL, 5 mL, | inquiry |
ASSD-219 | Tetramethylrhodamine-6-maleimide (AC219) | 5 mg | inquiry |
ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg | inquiry |
ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
ASSD-101 | Cresyl Violet Solution (1%) (AC101) | 250 mL, 500 mL, | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.